Business
Patent to 2034 granted in Europe for Neurens NNZ-2591
Patent to 2034 granted in Europe for Neurens NNZ-2591
About this update from Neuren Pharmaceuticals Limited
[{"type":"text","content":"Neuren Pharmaceuticals Ltd has released a press release. View Attachment","length":250,"tagName":"div"}]